Loading clinical trials...
Loading clinical trials...
Two-Week, Open-Label, Exploratory Neuroimaging Study Evaluating the Effect of Dextromethorphan-HBr Bupropion-HCl on Striatal Reactivity During Reward Processing in Adults With Major Depressive Disorder
Conditions
Interventions
Dextromethorphan-Bupropion
Locations
1
Canada
Brain and Cognition Discovery Foundation
Toronto, Ontario, Canada
Start Date
November 21, 2025
Primary Completion Date
July 1, 2026
Completion Date
January 1, 2027
Last Updated
April 13, 2026
NCT07226661
NCT06793397
NCT07025720
NCT06804525
NCT07462013
NCT06601140
Lead Sponsor
Roger McIntyre
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions